An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, such as cirrhosis or liver…
E2F2 protein identified as potential therapeutic target to prevent metabolic fatty liver disease progression
